Literature DB >> 34213492

Modified malleable prosthesis with a fixed mesh: case series for the Ghattas technique.

Osama Ghattas1, Mohamed Fahmy Doheim2, Hossam Kotb1, Arthur L Burnett3.   

Abstract

Penile prosthetic implantation represents a cornerstone for patients with organic erectile dysfunction (ED) that is refractory, unsatisfactory, or contra-indicated for other approved medical or mechanical options. In this study, we introduce the "Ghattas technique," wherein we constructed a polypropylene mesh sheath that surrounds and is fixed to a 13-mm malleable prosthesis cylinder, which can increase the cylinder diameter for cases that need a larger prosthesis. All patients underwent preoperative evaluation and completed the five-item International Index of Erectile Function questionnaire (IIEF-5). Postoperative outcomes were evaluated by IIEF-5 and Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) questionnaires at final follow-up. The mean age of the 23 included patients was 57.9 (standard deviation [s.d.]: 11.4) years and the mean duration of ED was 8.5 (s.d.: 7.9) years. Erection improvement was determined by comparing mean preoperative and postoperative IIEF-5 scores (8.3 [s.d.: 3.9] vs 24.6 [s.d.: 0.6], P < 0.001). High treatment satisfaction was determined according to a mean EDITS score of 94.9 (s.d.: 9.9). The proposed Ghattas technique was safe and effective in our patients, and provides opportunity for cases that need a diameter larger than 13 mm. Further studies are needed to confirm these results.

Entities:  

Keywords:  erectile dysfunction; mesh; penile prosthesis; surgical technique

Mesh:

Year:  2022        PMID: 34213492      PMCID: PMC8887114          DOI: 10.4103/aja.aja_55_21

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


INTRODUCTION

Penile prosthetic implantation is a main line of treatment for patients with organic erectile dysfunction (ED) that is refractory, contra-indicated, or unsatisfactory for other approved options.12 A malleable (noninflatable or semi-rigid) penile prosthesis provides a valid implant option. Although inflatable prostheses are associated with higher satisfaction rates, malleable devices require less complex and cheaper surgical procedures and exhibit infrequent mechanical failure.3 Moreover, malleable prostheses may be the preferred choice under indications such as poor hand dexterity, a posttraumatic “hostile” pelvis, neobladders, prior bilateral hernia surgery, major fibrosis of the corpus cavernosum, complex anatomies, or infection after salvage surgery.4 A malleable prosthesis typically comprises a pair of rods made of either a spiral wire core or silicone material, encased in fabric such as a silicone or polyurethane jacket. Among the market varieties, there is no diameter larger than 13 mm. However, during clinical practice, we have encountered some special cases that require diameters larger than 13 mm because of an enlarged penis. We have observed that the implantation of prostheses of 13-mm diameter usually resulted in unsatisfactory outcomes reported by such patients. In these cases, patients complained of a shortened penis, penile floppiness, and breakage of the prosthesis. We determined that these outcomes were related to the undersized penile prosthesis and consequent instability of the implants within the corporal body.5 Therefore, to increase the cylinder size of prostheses for specific cases that need a cylinder diameter larger than 13 mm, our current study used the “Ghattas technique,” wherein we used a sheath constructed from a polypropylene mesh (Ethicon US, LLC, Cincinnati, OH, USA) that was fixed to a 13-mm prosthesis cylinder.

PATIENTS AND METHODS

We examined patients with organic ED who underwent the Ghattas implantation technique, described below, from October 2018 to May 2020 at Mary Markus Hospital, Alexandria, Egypt. All patients underwent preoperative evaluation, including medical history, physical examination, lab testing, and penile color Doppler ultrasonography. In all patients, past treatment had failed or had been rejected (oral, intracavernous self-injection, or vacuum devices). Preoperatively, patients were evaluated using the five-item International Index of Erectile Function questionnaire (IIEF-5) to determine their erectile function domain scores.6 All patients underwent a psychiatric evaluation preoperatively and those with psychiatric disorders were found unsuitable for prosthesis implantation. Informed consent was taken from all the patients, with information explaining the types and technical characteristics of the device. Patients were asked to give consent for their photos to be taken during surgery.

Surgical technique

At the beginning of surgery, after inserting a transurethral catheter, a ventral incision was made to reveal both corpora cavernosa. Bilateral sling sutures were placed on both cavernous bodies and a corporotomy incision of approximately 2.5 cm in each corporal body provided sufficient access for dilatation. After measuring intracorporal dimensions, irrigation was performed with an antibiotic solution and gloves were changed. For intracorporal diameters 13 mm or less after dilation, prostheses were implanted without modification. For intracorporal diameters more than 13 mm after dilatation, we constructed a sheath of polypropylene mesh, as used in surgeries such as hernia repair, that was approved as safe and sterile. This technique entails wrapping the mesh around a 13-mm penile prosthesis cylinder and modifying the number of layers of mesh wrapped around the prosthesis to fit the apparent size of the corporal body. Then, the mesh was fixed to the prosthesis using polypropylene stitches (). After placing the ensheathed penile prosthesis cylinder within the corporal body (), the surgical wound was closed in layers and the penis dressed with an elastic bandage. Modified malleable prosthesis with mesh fixation compared with the standard 13-mm diameter prosthesis. A penis after implanting the modified malleable implant into the corpora cavernosa.

Outcome measures

Outcomes were further evaluated by IIEF-5 and the Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) questionnaire at the final follow-up.7 Complications were also assessed.

Statistical analyses

Statistical analyses were performed by SPSS version 25 (Statistical Packages for the Social Sciences, Chicago, IL, USA). Qualitative data were described using number and percentage. We described quantitative data using range, mean, and standard deviation (s.d.). To compare preoperative and postoperative IIEF-5 scores, the Wilcoxon signed-rank nonparametric test was used. P < 0.05 was considered statistically significant.

RESULTS

We identified 39 patients, of which 23 had complete datasets and follow-up examinations that were suitable for inclusion in this study. The mean age of patients was 57.9 (s.d.: 11.4, range: 37–73) years, and the mean duration of ED was 8.5 (s.d.: 7.9) years. Among the 23 patients, 14 were diagnosed with vasculogenic ED and the others had nonvasculogenic ED. Our cases included six patients who underwent the Ghattas surgical technique as a revision because of complications associated with prior undersized prosthetic cylinders (five had broken cylinders). The mean follow-up was 5.5 (s.d.: 3.4) months with the longest follow-up of 18 months. Patients’ demographics and comorbidities are summarized in . Patients’ demographics and comorbidities (n=23) s.d.: standard deviation Erection status was significantly improved following surgery, comparing preoperative and postoperative IIEF-5 domain values in all domains and overall scores (). The assessment of each domain is summarized in . We found increased IIEF-5 scores for the six patients who underwent surgical revisions with the new technique, with mean baseline scores of 5.7 (s.d.: 0.8) to postoperative scores of 24.3 (s.d.: 0.8; P < 0.001). The mean follow-up was 8.2 (s.d.: 5.3) months for all patients. High treatment satisfaction was also shown by EDITS (). A summary of responses for EDITS questions are provided in . For postoperative complications, postoperative mild to moderate penile pain was reported subjectively in four (17.4%) patients and was relieved gradually through follow-up, and delayed ejaculation was reported in two (8.7%) patients. Pre- and postoperative scores of IIEF-5 questionnaire and EDITS of the included patients IIEF-5: the five-item International Index of Erectile Function questionnaire; EDITS: Erectile Dysfunction Inventory of Treatment Satisfaction; NA: not applicable; s.d.: standard deviation The results of Erectile Dysfunction Inventory of Treatment Satisfaction patients’ survey Preoperative and postoperative the five-item International Index of Erectile Function questionnaire domain values of the patients IIEF-5: the five-item International Index of Erectile Function questionnaire. P < 0.05 is considered statistically significant

DISCUSSION

Historically, Bogoras used cartilage from the ribcage of animals to enable penile erection in the 1930s.8 As early as the 1970s, penile prostheses with different functional and structural characteristics were developed with advanced technology.8 Penile prostheses have been frequently used as a tertiary treatment in cases with ED that do not respond to nonsurgical treatments, such as oral therapies and intracavernosal injections, or for those who cannot use these treatments for different reasons.12 During the selection of prosthesis type, it is important to consider the features, expectations, and wishes of patients.9 Our study presents a new technique, in which we used a polypropylene mesh sheath fixed to a 13-mm prosthesis to increase the prosthesis diameter for specific cases requiring a diameter larger than 13 mm. The current outcome results were promising, with a significant increase in IIEF-5 scores after surgery compared with baseline showing the clinical importance of this technique. Likewise, the results of EDITS were very satisfactory after surgery. These results were considered successful and included scores higher than previous reports by other authors that assessed malleable prostheses using standard techniques.910 The new technique has clinical importance for special cases that need a cylinder diameter of more than 13 mm (the largest available diameter). To date, the implantation of a prosthesis with a cylinder diameter of 13 mm for such cases usually results in unsatisfactory intercourse outcomes reported by patients and shrinkage in penile size occurs after a few months. We highlight that the current study did not aim to produce oversized penile augmentation because this may lead to several known problems but intended to achieve an optimal cylinder diameter when there was the likelihood of an undersized prosthesis. For instance, such situations may occur when a patient needs a prosthesis with a 13-mm diameter and we start with a cylinder diameter of 9 mm, or where a patient needs a prosthesis with a 17-mm diameter and we start with a cylinder diameter of 13 mm. We can increase the diameter as needed for each of these cases by modifying the number of layers of mesh wrapped around the prosthesis. There are two benefits possible with this surgical modification: optimization of the prosthesis diameter and more comfortable positioning of the prosthesis in the penis, together achieving greater satisfaction for the patient. The malleability was decreased slightly, depending on the number of wrapped layers, but not to a significant extent, because we used a mesh that was too soft to interfere in a noticeable way. We also speculate that prosthesis cylinders with a diameter larger than 13 mm, if made available, would be too cumbersome for manipulation in a normal position when not performing sexual intercourse. Additionally, a longer corporotomy was not needed to insert the implant that was used in this study. It is worth noting that six of our patients underwent previously failed implantations because of diameter limitations and subsequent complications as mentioned above. These patients achieved highly satisfactory results following revision surgery with our new Ghattas technique. Thus, the Ghattas technique could provide benefits in these specific situations. Our surgical technique presented with minimal complications in the form of pain and delayed ejaculation, both of which resolved over time through follow-up. In a recent study, postoperative complications from standard prosthesis surgery included penile edema (13.1%), penile pain (8.7%), delayed ejaculation (6.5%), infection (2.2%), cylinder crossover (2.2%), distal cavernosal erosion (2.2%) and numbness of the glans (2.2%).9 Infection is typically the most serious complication of prosthesis implantation. Infection rates have been reported to be reduced by frequent disinfection of the surgical area, preoperative use of prophylactic antibiotics and sustaining them 3–7 days postoperatively, care of the surgical area, and surgery being performed by experienced surgeons.1112 There were no infected cases observed in our study. A patient undergoing our proposed technique (not included in this study) underwent a revision. In this case, the patient had a large penis but small glans penis, and he was not satisfied with the Rigicon prosthesis after implantation. A revision was done using a Coloplast prosthesis, which had a tapering end tail that was well-fitted to his small glans penis. During exploratory surgery 6 months after his initial surgery, the mesh was almost adherent to the pseudocapsule tunica and the prosthesis was freely mobile with a space filled with blood between the mesh and prosthesis. The prosthesis was easily extracted and the mesh was removed without difficulty. It is noteworthy that the patient underwent the Ghattas technique with new mesh fixed to the Coloplast prosthesis and he was very satisfied at follow-up. This study used a type of mesh that was the most available and typically used safely in humans, as in hernia repair. However, on the basis of the case mentioned above, we note that this material for ensheathing the cylinder may be one limitation of this technique, because in some cases, the mesh may not be easily dissected from the tunica during re-exploration. This study may provide the foundation to encourage specialized companies to find more suitable materials to be used as the outer jacket, with adjustable layers or customized diameters as needed in certain cases. To the best of our knowledge, this is the first study to investigate and report the use of mesh fixed to a cylinder to increase the prosthesis diameter when needed during implantation. The application of adjunct materials as acellular dermal matrix tissues with prosthetic cylinders in penile implantation surgery was previously described for tunica albuginea replacement and reconstructive purposes.13 However, the use of mesh in the current work was to fortify and stabilize the cylinders and ensure optimal penile girth, but not to provide a tunica substitute. To summarize, we present the Ghattas technique in which a polypropylene mesh sheath is fixed to a 13-mm prosthesis to increase the prosthesis size for cases that need a diameter larger than 13 mm. The technique was safe and effective in our patients. Further prospective studies with larger sample sizes and long-term follow-up are needed to confirm these results.

AUTHOR CONTRIBUTIONS

OG set the idea and concept of the study, collected data, led the writing of the manuscript, and revised and edited the manuscript. MFD analyzed and interpreted the data and shared in the writing of the manuscript. HK collected data and shared in the writing and editing of the manuscript. ALB revised and edited the manuscript and supervised this study. All authors read and approved the final manuscript.

COMPETING INTERESTS

All authors declare no competing interests. Supplementary Information is linked to the online version of the paper on the Asian Journal of Andrology website.
Table 1

Patients’ demographics and comorbidities (n=23)

Variable Value
Age (year), mean±s.d. (range)57.9±11.4 (37–73)
Duration (year), mean±s.d. (range)8.5±7.9 (1–29)
Diabetes, n (%)7 (30.4)
Hypertension, n (%)3 (13.1)
Smoking, n (%)4 (17.4)
Prosthetic replacement, n (%)6 (26.1)

s.d.: standard deviation

Table 2

Pre- and postoperative scores of IIEF-5 questionnaire and EDITS of the included patients

Parameter Preoperative Postoperative (Ghattas technique) P
IIEF-5 (overall), mean±s.d.8.3±3.924.6±0.6<0.001
EDITS score (range: 0–100%), mean±s.d.NA94.9±9.9NA

IIEF-5: the five-item International Index of Erectile Function questionnaire; EDITS: Erectile Dysfunction Inventory of Treatment Satisfaction; NA: not applicable; s.d.: standard deviation

Supplementary Table 1

The results of Erectile Dysfunction Inventory of Treatment Satisfaction patients’ survey

Questions Answers (n=23), n (%)
1. Overall how satisfied are you with penile prosthesis?
 Very satisfied19 (83)
 Somewhat satisfied3 (13)
 Neither satisfied nor dissatisfied1 (4)
 Somewhat dissatisfied0
 Very dissatisfied0
2. To what degree has penile prosthesis met your expectations?
 Completely17 (74)
 Considerably5 (22)
 Half way1 (4)
 A little0
 Not at all0
3. How likely are you to continue using penile prosthesis?
 Very likely21 (91)
 Moderate likely1 (4)
 Neither likely nor unlikely0
 Moderate unlikely1 (4)
 Very unlikely0
4. How easy was it for you to use penile prosthesis?
 Very easy22 (96)
 Moderately easy0
 Neither easy nor difficult1 (4)
 Moderately difficult0
 Very difficult0
5. During the past four weeks, how satisfied have you been with how quickly are treatment work?
 Very satisfied23 (100)
 Somewhat satisfied0
 Neither satisfied nor dissatisfied0
 Somewhat dissatisfied0
 Very dissatisfied0
6. During the past four weeks, how satisfied have you been with how long the treatment lasts?
 Very satisfied21 (91)
 Somewhat satisfied2 (9)
 Neither satisfied nor dissatisfied0
 Somewhat dissatisfied0
 Very dissatisfied0
7. How confident has penile prosthesis made you feel about your ability to engage in sexual activity?
 Very confident23 (100)
 Somewhat confident0
 It has had no impact0
 Somewhat less confident0
 Very much less confident0
8. Overall how satisfied do you believe your partner is with effects of penile prosthesis?
 Very satisfied19 (83)
 Somewhat satisfied2 (9)
 Neither satisfied nor dissatisfied0
 Somewhat dissatisfied2 (9)
 Very dissatisfied0
9. How does your partner feel about your continuing to use penile prosthesis?
 Absolutely wants me to continue21 (91)
 Generally prefers me to continue0
 Has no opinion1 (4)
 Generally prefers me to stop0
 Absolutely wants me to stop1 (4)
10. How natural did the process of achieving an erection feel when you used this treatment over the past 4 weeks?
 Very natural18 (78)
 Somewhat natural4 (17)
 Neither natural nor unnatural0
 Somewhat unnatural1 (4)
 Very unnatural0
11. Compared to before you had an erection problem how would you rate the naturalness of your erection when you used this treatment over the past 4 weeks in terms of hardness?
 A lot harder than before I had an erection problem19 (83)
 Somewhat harder than before I had an erection problem3 (13)
 The same hardness as before I had an erection problem0
 Somewhat less hard than before I had an erection problem1 (4)
 A lot less hard than before I had an erection problem0
Supplementary Table 2

Preoperative and postoperative the five-item International Index of Erectile Function questionnaire domain values of the patients

Preoperative Postoperative (new technique) P
How do you rate your confidence that you could get and keep an erection?1.64±0.855±0<0.001
When you had erections with sexual stimulation, how often were your erections hard enough for penetration?1.86±1.135±0<0.001
During sexual intercourse, how often were you able to maintain your erection after you had penetrated (entered) your partner1.55±0.915±0<0.001
During sexual intercourse, how difficult was it to maintain your erection to completion of intercourse?1.55±1.055±0<0.001
When you attempted sexual intercourse, how often was it satisfactory for you?1.59±0.854.64±0.58<0.001
IIEF-5 (overall)8.27±3.8724.64±0.58<0.001

IIEF-5: the five-item International Index of Erectile Function questionnaire. P < 0.05 is considered statistically significant

  12 in total

1.  Nikolaj A. Bogoraz (1874-1952): pioneer of phalloplasty and penile implant surgery.

Authors:  Dirk Schultheiss; Alexander I Gabouev; Udo Jonas
Journal:  J Sex Med       Date:  2005-01       Impact factor: 3.802

Review 2.  The use of penile prostheses in the treatment of impotence.

Authors:  C Evans
Journal:  Br J Urol       Date:  1998-04

3.  Long-term outcomes of AMS Spectra® penile prosthesis implantation and satisfaction rates.

Authors:  F Akdemir; E Okulu; Ö Kayıgil
Journal:  Int J Impot Res       Date:  2017-04-20       Impact factor: 2.896

4.  Satisfaction assessment with malleable prosthetic implant of Spectra (AMS) and Genesis (Coloplast) models.

Authors:  A R Casabé; N Sarotto; C Gutierrez; A J Bechara
Journal:  Int J Impot Res       Date:  2016-08-25       Impact factor: 2.896

5.  [Penile prosthesis in case of impotence: 12 years of clinical experience].

Authors:  R Andrianne; S Balde; J de Leval; P Kempeners; C Mormont
Journal:  Acta Urol Belg       Date:  1995-03

6.  EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction.

Authors:  S E Althof; E W Corty; S B Levine; F Levine; A L Burnett; K McVary; V Stecher; A D Seftel
Journal:  Urology       Date:  1999-04       Impact factor: 2.649

Review 7.  The Evolution and Utility of the Small-Carrion Prosthesis, Its Impact, and Progression to the Modern-Day Malleable Penile Prosthesis.

Authors:  Daniel R Martinez; Ryan Terlecki; William O Brant
Journal:  J Sex Med       Date:  2015-11       Impact factor: 3.802

8.  Long term patient satisfaction and quality of life with AMS700CX inflatable penile prosthesis.

Authors:  Antonio Vitarelli; Lucia Divenuto; Francesca Fortunato; Antonio Falco; Vincenzo Pagliarulo; Gabriele Antonini; Vincenzo Gentile; Alessandro Sciarra; Stefano Salciccia; Salvatore Sansalone; Maria Rosaria Di Placido; Giulio Garaffa; Arcangelo Pagliarulo
Journal:  Arch Ital Urol Androl       Date:  2013-09-26

9.  Erectile Dysfunction: AUA Guideline.

Authors:  Arthur L Burnett; Ajay Nehra; Rodney H Breau; Daniel J Culkin; Martha M Faraday; Lawrence S Hakim; Joel Heidelbaugh; Mohit Khera; Kevin T McVary; Martin M Miner; Christian J Nelson; Hossein Sadeghi-Nejad; Allen D Seftel; Alan W Shindel
Journal:  J Urol       Date:  2018-05-07       Impact factor: 7.450

Review 10.  Acellular Dermal Matrix Tissues in Genitourinary Reconstructive Surgery: A Review of the Literature and Case Discussions.

Authors:  Nora M Haney; Mitchell M Huang; James L Liu; Dorota J Hawksworth; Arthur L Burnett
Journal:  Sex Med Rev       Date:  2020-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.